Fields »
ABOUT
HELP
BLOG

366 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 8 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
ZNF385BZinc finger protein 385BPredicted intracellular proteins
Nucleoli fibrillar centerRenal cancer: 1.04e-9
Breast cancer: 4.86e-8
Tissue enhanced
TFPI2Tissue factor pathway inhibitor 2Predicted intracellular proteins
Predicted secreted proteins
Breast cancer: 8.33e-7
Endometrial cancer: 5.42e-4
Renal cancer: 8.53e-4
Tissue enriched
IL27RAInterleukin 27 receptor, alphaPredicted membrane proteins
Vesicles
Cytosol		Renal cancer: 2.58e-10
Breast cancer: 1.74e-6
Mixed
JCHAINJoining chain of multimeric IgA and IgMPlasma proteins
Predicted secreted proteins
Head and neck cancer: 7.56e-7
Breast cancer: 1.81e-6
Renal cancer: 1.40e-4
Expressed in all
ARID5AAT rich interactive domain 5A (MRF1-like)Predicted intracellular proteins
Transcription factors
Nucleus
Nucleoli		Renal cancer: 4.24e-8
Breast cancer: 2.05e-6
Expressed in all
MAP2K6Mitogen-activated protein kinase kinase 6Enzymes
Predicted intracellular proteins
Nucleus
Cytosol		Breast cancer: 2.27e-6
Pancreatic cancer: 7.52e-4
Mixed
NEFHNeurofilament, heavy polypeptideDisease related genes
Predicted intracellular proteins
Nucleus
Nuclear bodies
Centrosome		Breast cancer: 2.33e-6
Tissue enriched
DEF6DEF6 guanine nucleotide exchange factorPredicted intracellular proteins
NucleoplasmRenal cancer: 1.02e-8
Breast cancer: 3.02e-6
Cervical cancer: 1.08e-4
Colorectal cancer: 1.71e-4
Endometrial cancer: 2.37e-4
Mixed
C6orf141Chromosome 6 open reading frame 141Predicted intracellular proteins
Nuclear membraneBreast cancer: 3.92e-6
Endometrial cancer: 1.15e-4
Tissue enhanced
CA3Carbonic anhydrase IIIEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Breast cancer: 4.24e-6
Tissue enriched
GSTK1Glutathione S-transferase kappa 1Enzymes
Plasma proteins
Predicted intracellular proteins
PeroxisomesRenal cancer: 2.10e-6
Breast cancer: 4.41e-6
Expressed in all
PEX10Peroxisomal biogenesis factor 10Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
NucleoplasmRenal cancer: 4.16e-6
Breast cancer: 4.50e-6
Expressed in all
SGK3Serum/glucocorticoid regulated kinase family, member 3Enzymes
Predicted intracellular proteins
Breast cancer: 5.52e-6
Cervical cancer: 8.28e-4
Pancreatic cancer: 9.65e-4
Expressed in all
SLC5A8Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8Predicted membrane proteins
Breast cancer: 9.04e-6
Renal cancer: 1.97e-4
Tissue enhanced
RAC2Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)Disease related genes
Predicted intracellular proteins
RAS pathway related proteins
Renal cancer: 1.06e-6
Breast cancer: 1.03e-5
Expressed in all
PIGRPolymeric immunoglobulin receptorCancer-related genes
Plasma proteins
Predicted membrane proteins
Nucleus
Nucleoli
Cytosol		Breast cancer: 1.22e-5
Renal cancer: 5.08e-5
Endometrial cancer: 2.57e-4
Tissue enhanced
ZMYM6Zinc finger, MYM-type 6Predicted intracellular proteins
Predicted membrane proteins
NucleoplasmBreast cancer: 1.30e-5
Mixed
NFKBIANuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alphaCancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
CytosolBreast cancer: 1.33e-5
Expressed in all
TNFRSF17Tumor necrosis factor receptor superfamily, member 17Cancer-related genes
CD markers
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Head and neck cancer: 1.58e-6
Breast cancer: 1.35e-5
Tissue enhanced
RARRES3Retinoic acid receptor responder (tazarotene induced) 3Predicted intracellular proteins
Predicted membrane proteins
Pancreatic cancer: 6.26e-6
Breast cancer: 1.35e-5
Cervical cancer: 4.00e-4
Expressed in all
SERPINA1Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesBreast cancer: 1.61e-5
Colorectal cancer: 5.86e-4
Tissue enriched
NFKBIENuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilonCancer-related genes
Predicted intracellular proteins
Transcription factors
Nucleus
Nucleoli fibrillar center
Cytosol		Renal cancer: 1.37e-6
Breast cancer: 1.72e-5
Liver cancer: 3.50e-4
Urothelial cancer: 8.07e-4
Mixed
TRAPPC12Trafficking protein particle complex 12Plasma proteins
Predicted intracellular proteins
Breast cancer: 1.80e-5
Renal cancer: 2.44e-4
Pancreatic cancer: 9.15e-4
Expressed in all
CD52CD52 moleculeCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Breast cancer: 1.85e-5
Endometrial cancer: 2.06e-4
Head and neck cancer: 4.45e-4
Renal cancer: 5.85e-4
Tissue enriched
RASGEF1ARasGEF domain family, member 1APredicted intracellular proteins
Golgi apparatusRenal cancer: 4.11e-7
Breast cancer: 1.86e-5
Endometrial cancer: 4.28e-4
Tissue enhanced
C6orf226Chromosome 6 open reading frame 226Predicted intracellular proteins
Nuclear specklesBreast cancer: 1.93e-5
Renal cancer: 3.35e-4
Pancreatic cancer: 5.13e-4
Expressed in all
TIPARPTCDD-inducible poly(ADP-ribose) polymeraseEnzymes
Predicted intracellular proteins
Nucleoplasm
Microtubules
Microtubule organizing center		Breast cancer: 2.00e-5
Expressed in all
CEBPDCCAAT/enhancer binding protein (C/EBP), deltaPredicted intracellular proteins
Transcription factors
NucleoplasmRenal cancer: 2.87e-7
Breast cancer: 2.28e-5
Expressed in all
BEND5BEN domain containing 5Predicted intracellular proteins
Nuclear speckles
Cytosol		Urothelial cancer: 8.30e-6
Breast cancer: 2.50e-5
Pancreatic cancer: 1.29e-4
Lung cancer: 1.29e-4
Mixed
ARL14EPADP-ribosylation factor-like 14 effector proteinPredicted intracellular proteins
Nucleus
Vesicles
Focal adhesion sites
Cytosol		Breast cancer: 2.50e-5
Liver cancer: 5.26e-4
Urothelial cancer: 7.49e-4
Expressed in all
APOBEC3DApolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3DPredicted intracellular proteins
Renal cancer: 3.76e-7
Breast cancer: 2.51e-5
Cervical cancer: 1.31e-4
Urothelial cancer: 3.01e-4
Endometrial cancer: 4.47e-4
Mixed
KRTCAP3Keratinocyte associated protein 3Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Cytosol		Breast cancer: 2.67e-5
Mixed
CFBComplement factor BDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Vesicles
Cell Junctions		Renal cancer: 1.53e-5
Breast cancer: 2.76e-5
Tissue enriched
CCL19Chemokine (C-C motif) ligand 19Cancer-related genes
Predicted secreted proteins
Renal cancer: 8.63e-7
Cervical cancer: 9.91e-6
Breast cancer: 2.88e-5
Group enriched
SNX22Sorting nexin 22Predicted intracellular proteins
Nucleoplasm
Vesicles		Breast cancer: 2.89e-5
Thyroid cancer: 2.19e-4
Tissue enhanced
SAV1Salvador family WW domain containing protein 1Predicted intracellular proteins
CytosolRenal cancer: 3.83e-6
Breast cancer: 2.92e-5
Expressed in all
CCDC24Coiled-coil domain containing 24Predicted intracellular proteins
Plasma membrane
Cytosol		Breast cancer: 3.06e-5
Liver cancer: 1.70e-4
Head and neck cancer: 3.18e-4
Tissue enhanced
CCBL2Cysteine conjugate-beta lyase 2Enzymes
Predicted intracellular proteins
Nucleoli
Cytosol		Renal cancer: 5.02e-6
Breast cancer: 3.19e-5
Head and neck cancer: 1.86e-4
Ovarian cancer: 2.80e-4
Expressed in all
CD69CD69 moleculeCD markers
Predicted membrane proteins
Breast cancer: 3.31e-5
Renal cancer: 7.87e-5
Tissue enhanced
STOX1Storkhead box 1Disease related genes
Predicted secreted proteins
Nucleoplasm
Nucleoli fibrillar center
Cytosol		Breast cancer: 3.37e-5
Lung cancer: 2.08e-4
Tissue enhanced
KLRB1Killer cell lectin-like receptor subfamily B, member 1CD markers
Predicted membrane proteins
Nucleoplasm
Cytosol		Endometrial cancer: 1.42e-5
Breast cancer: 3.51e-5
Head and neck cancer: 6.99e-5
Thyroid cancer: 5.61e-4
Mixed
ENDOVEndonuclease VPredicted intracellular proteins
Breast cancer: 4.24e-5
Colorectal cancer: 4.40e-4
Expressed in all
MS4A1Membrane-spanning 4-domains, subfamily A, member 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Breast cancer: 4.34e-5
Group enriched
BTG1B-cell translocation gene 1, anti-proliferativeCancer-related genes
Disease related genes
Predicted intracellular proteins
Nucleoplasm
Cytosol		Renal cancer: 1.95e-7
Breast cancer: 4.36e-5
Expressed in all
TNFRSF14Tumor necrosis factor receptor superfamily, member 14Cancer-related genes
CD markers
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Cytosol
Rods & Rings		Urothelial cancer: 7.79e-6
Endometrial cancer: 8.01e-6
Breast cancer: 4.39e-5
Expressed in all
SPIBSpi-B transcription factor (Spi-1/PU.1 related)Predicted intracellular proteins
Transcription factors
Head and neck cancer: 2.14e-5
Breast cancer: 4.76e-5
Tissue enhanced
MYBPC1Myosin binding protein C, slow typeDisease related genes
Predicted intracellular proteins
Breast cancer: 4.76e-5
Tissue enriched
TRIM21Tripartite motif containing 21Plasma proteins
Predicted intracellular proteins
NucleoplasmThyroid cancer: 2.26e-6
Breast cancer: 4.83e-5
Liver cancer: 1.87e-4
Expressed in all
C17orf107Chromosome 17 open reading frame 107Predicted intracellular proteins
NucleusBreast cancer: 5.06e-5
Renal cancer: 2.68e-4
Pancreatic cancer: 8.61e-4
Mixed
FAM117AFamily with sequence similarity 117, member APredicted intracellular proteins
NucleoplasmLung cancer: 8.25e-7
Breast cancer: 5.30e-5
Pancreatic cancer: 1.81e-4
Expressed in all

Page of 8 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.